Sustainability & Climate

Copper Quest diversifies from copper, acquiring a high-grade gold mine and adding 150+ years of mining expertise to its board and advisory team.

With new clinical data and recent FDA approval, IceCure Medical's tumor-freezing tech is paving a new, less-invasive path for breast cancer treatment.

With extensive mineralization confirmed and $6M in fresh capital, SAGA Metals' Radar Project is rapidly de-risking a major critical minerals discovery.

Early Phase 1 data for VTP-1000 shows promise, but can this novel immunotherapy challenge a crowded market and change life for 80 million patients?

New data shows Kazia's paxalisib dismantles metastatic drivers and reignites immunity, signaling a strategic disruption in advanced breast cancer treatment.

A new, fully customizable quantum system promises to democratize R&D, fueling national strategies and accelerating discovery in science and medicine.

Glean's new research institute and context-aware agents offer a pragmatic path for businesses struggling to operationalize AI safely and effectively.

A new contract for specialized titanium powder signals a major shift in manufacturing, securing critical supply chains for a booming $1.4B market.

Del Webb's new Michigan community isn't just selling homes; it's selling a lifestyle. We dissect the business strategy behind its amenity-rich model.

With $47.5M and a veteran CEO, PsiThera is using its advanced AI platform to develop oral medicines for diseases long-dominated by injectable biologics.

MediWound's burn treatment now prevents traumatic tattoos from blasts and accidents, signaling a major strategic expansion and a new era in trauma care.

A French cancer institute is the first in Europe to deploy a new radiotherapy system that promises not just better accuracy, but a more humane patient journey.

Beijing 101 blends TCM with high-tech devices for scalp care. We analyze the business strategy behind this fusion in a competitive wellness market.

A new neuroscience framework reveals why ethical leaders attract criticism, shifting the focus from leadership flaws to the observer's own brain.

Beyond a simple FDA approval, Amneal's entry into the epinephrine vial market is a calculated move to fix a broken supply chain and drive growth.

A routine dividend from Morgan Stanley's China A-Share fund offers a deeper look into the risks and rewards of investing in China's domestic market.

A century-old brand just launched a giant, novelty product. It’s not a joke—it’s a calculated lesson in modern marketing and brand revitalization.

Beyond a tagline, The Aesthetic Society is expanding to include non-surgeons, a strategic move to set standards and consolidate influence in a booming market.

Amara Industries' strategic acquisition of Thomson Plastics signals a major shift, creating a tech-forward giant in North American injection molding.

A regulatory filing from Balyasny Asset Management reveals intense investor activity as a bidding war for narcolepsy drugmaker Avadel heats up.